Drug Utilization and Drug-Drug Interaction Studies in the Field: Examples of South-North Collaboration Projects

被引：0
|
作者：
Kuemmerle, A. [1 ,2 ]
Akakpo, S. [3 ]
Liwono, J. [3 ,4 ]
Duparc, S. [3 ]
Burri, C. [1 ,2 ]
Stergachis, A. [5 ,6 ]
机构：
[1] Swiss Trop & Publ Hlth Inst, Basel, Switzerland
[2] Univ Basel, Basel, Switzerland
[3] Med Malaria Venture, Geneva, Switzerland
[4] Clin Pharmacol & Pharmacovigilance Unit, Kinshasa, DEM REP CONGO
[5] Univ Washington, Sch Pharm, Seattle, WA 98195 USA
[6] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA
来源：
DRUG SAFETY | 2018年 / 41卷 / 11期
关键词：
MEDICINAL-PLANTS;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
O-032
引用
收藏
页码：1120 / 1121
页数：2
相关论文
共 50 条
  • [1] DRUG UTILIZATION AND POTENTIAL DRUG-DRUG INTERACTIONS
    LAVENTURIER, MF
    TALLEY, RB
    HEFNER, DL
    KENNARD, LH
    JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1976, 16 (02): : 77 - 81
  • [2] Pediatric Drug-Drug Interaction Studies: Barriers and Opportunities
    Salerno, Sara N.
    Burckart, Gilbert J.
    Huang, Shiew-Mei
    Gonzalez, Daniel
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (05) : 1067 - 1070
  • [3] Regulatory and Scientific Aspects of Drug-Drug Interaction Studies
    Greenblatt, David J.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2012, 1 (02): : 43 - +
  • [4] A survey of drug-drug interaction (DDI) studies.
    Marroum, P
    Burnett, A
    Svadjian, R
    Uppoor, RS
    Ajayi, F
    Yuan, R
    Lesko, LJ
    Balian, JD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 147 - 147
  • [5] Power Calculation for Drug-Drug Interaction in Safety Studies
    Cai, Bing
    Zhou, Xiaofeng
    Bate, Andrew J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S309 - S310
  • [6] Understanding the Drug-Drug Interaction
    Yim, Dong-Seok
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2006, 49 (01): : 78 - 85
  • [7] Drug Repurposing Based on Drug-Drug Interaction
    Zhou, Bin
    Wang, Rong
    Wu, Ping
    Kong, De-Xin
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (02) : 137 - 144
  • [8] Drug-Drug Interaction Studies Look beyond CYP Activity
    Salzman S.
    Genetic Engineering and Biotechnology News, 2019, 39 (09): : 32 - 34
  • [9] Drug-Drug Interaction Studies: Regulatory Guidance and An Industry Perspective
    Prueksaritanont, Thomayant
    Chu, Xiaoyan
    Gibson, Christopher
    Cui, Donghui
    Yee, Ka Lai
    Ballard, Jeanine
    Cabalu, Tamara
    Hochman, Jerome
    AAPS JOURNAL, 2013, 15 (03): : 629 - 645
  • [10] Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies
    Andrea Treyer
    Mohammed Ullah
    Neil Parrott
    Birgit Molitor
    Stephen Fowler
    Per Artursson
    The AAPS Journal, 21
12345